Access divergence to new cancer medicines in the United Kingdom.
Autor: | Lythgoe MP; Department of Surgery and Cancer, Imperial College London, London, UK. Electronic address: M.Lythgoe@imperial.ac.uk., Blagden S; Department of Oncology, University of Oxford, Oxford, UK., Stanway S; Royal Marsden Hospital, Sutton Surrey SM2 5PT, UK., Sullivan R; Institute of Cancer Policy, King's College London, London WC2R 2LS, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114131. Date of Electronic Publication: 2024 May 24. |
DOI: | 10.1016/j.ejca.2024.114131 |
Abstrakt: | Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. |
Databáze: | MEDLINE |
Externí odkaz: |